Overbrook Management’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
Overbrook Management's ICCC Position: Q3 2024 in Review
Overbrook Management sold out of ImmuCell (ICCC) in Q3 2024, closing a stake of 32,857 shares — an estimated $159K sold.
Overbrook Management first reported a position in ICCC in Q2 2020 and held it in 17 quarters. The position peaked at $843K in Q1 2021. 22 funds tracked by Wall St. Rank hold ICCC as of Q3 2024.
- Overbrook Management reported no remaining ImmuCell position as of Q3 2024 after selling out during the quarter.
- Overbrook Management sold 32,857 ImmuCell shares in Q3 2024, an estimated $159K.
- Overbrook Management first reported a position in ImmuCell in Q2 2020 and held it in 17 quarters.
- Overbrook Management's ImmuCell position peaked at $843K in Q1 2021.
- 22 funds tracked by Wall St. Rank held ImmuCell as of Q3 2024.
Based on Overbrook Management's 13F filing for Q3 2024, filed 8 Nov 2024.